Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Rybelsus (semaglutide) Rybelsus is a GLP-1 agonist with the active ingredient is semaglutide, like Ozempic and Wegovy
Moravek, M
Skye is advancing its next-generation peripheral CB1 inhibitor, nimacimab, with the goal of uniquely realizing the potential of this mechanism as an alternative anti-obesity therapeutic with potentially healthier, more sustainable clinical outcomes
Enhanced Fat Metabolism: Once inside the mitochondria, these fatty acids can be burned (oxidized) to produce energy, thus promoting efficient fat metabolism
Like any medication, GLP-1s can come with side effects
US$ 21.84
US$ 25.26
US$ 29.45
US$ 27.29
US$ 29.02
